Table 1.
Characteristics of patients on dialysis followed with monthly RBD antibody tests
| Vaccinated* N=2563 |
Partially vaccinated^ N=677 |
Unvaccinated N=1551 |
Overall N=4791 |
|
|---|---|---|---|---|
| Age (years) | 64.7 (13.8) | 63.8 (13.4) | 61.0 (14.5) | 63.4 (14.1) |
| 18 to 44 | 202 (7.9) | 65 (9.6) | 232 (15.0) | 499 (10.4) |
| 45 to 64 | 1008 (39.3) | 258 (38.1) | 631 (40.7) | 1897 (39.6) |
| 65 to 79 | 980 (38.2) | 284 (42.0) | 529 (34.1) | 1793 (37.4) |
| ≥ 80 | 373 (14.6) | 70 (10.3) | 159 (10.3) | 602 (12.6) |
|
| ||||
| Women | 1059 (41.3) | 288 (42.5) | 674 (43.5) | 2021 (42.2) |
|
| ||||
| Race and Ethnicity | ||||
| Hispanic | 357 (13.9) | 108 (16.0) | 172 (11.1) | 637 (13.3) |
| Non-Hispanic Black | 528 (20.6) | 177 (26.1) | 414 (26.7) | 1119 (23.4) |
| Non-Hispanic Other$ | 431 (16.8) | 89 (13.2) | 165 (10.6) | 685 (14.3) |
| Non-Hispanic White | 776 (30.3) | 190 (28.1) | 457 (29.5) | 1423 (29.7) |
| Missing | 471 (18.4) | 113 (16.7) | 343 (22.1) | 927 (19.4) |
|
| ||||
| Region | ||||
| Northeast | 278 (10.9) | 57 (8.4) | 145 (9.4) | 480 (10.0) |
| South | 1045 (40.8) | 394 (58.2) | 933 (60.2) | 2372 (49.5) |
| Midwest | 281 (11.0) | 56 (8.3) | 136 (8.8) | 473 (10.0) |
| West | 959 (37.4) | 170 (25.1) | 337 (21.7) | 1466 (30.6) |
|
| ||||
| Diabetes | 1514 (59.1) | 404 (59.7) | 852 (59.3) | 2770 (57.8) |
| Missing | - | - | 11 (0.7) | 11 (0.2) |
|
| ||||
| Vaccine Type | ||||
| mRNA1273 | 1259 (49.1) | 305 (45.1) | - | 1564 (32.6) |
| BNT162b2 | 1197 (46.7) | 361 (53.3) | - | 1558 (32.5) |
| Ad26.COV2.S | 107 (4.2) | - | - | 107 (2.2) |
*
Completed two doses of the mRNA vaccines or a single dose of the Ad2COVS vaccine at least 14 days prior to September 14, 2021.
^
Received only a single dose of mRNA vaccine prior to September 14, 2021.
$
Persons self-reporting Asian, American Indian, Alaskan, and Pacific Islander heritages are captured as ‘other.’